9
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T9271 | RAD51-IN-1 | DNA/RNA Synthesis | |
Rad51-in-1 is a derivative of B02 and an effective inhibitor of Rad51. | |||
T2276 | RI-1 | RI1,RAD51 inhibitor 1 | DNA/RNA Synthesis |
RI-1 (RAD51 inhibitor 1) is a RAD51 inhibitor (IC50: 5-30 μM). | |||
T6972 | RS-1 | DNA/RNA Synthesis | |
RS-1 is a RAD51 activator. RS-1 also increases CRISPR/Cas9-mediated knock-in efficiencies. | |||
T61469 | RAD51-IN-8 | ||
RAD51-IN-8, a new RAD51 binder, is a RAD51-BRCA2 inhibitor that inhibits the RAD51 BRCA2 protein protein interaction in the micromolar range. RAD51-IN-8 also is a protein protein interaction (PPI) inhibitor. RAD51-IN-8 h... | |||
T28536 | RI(dl)-2 TFA | RI(dl)-2 | |
RI(dl)-2 TFA is a potent and selective RAD51-mediated D-loop formation inhibitor with an IC 50 of 11.1 μM which also inhibits homologous recombination(HR) activity in human cells with IC50 of 3.0 μM[1]. | |||
T36703 | CAY10760 | ||
CAY10760 is an inhibitor of the protein-protein interaction between RAD51 recombinase and BRCA2 (EC50= 19 μM in a cell-free competitive ELISA).1It decreases homologous recombination by 54% in wild-typeBRCA2-expressing Bx... | |||
T14282 | Amuvatinib hydrochloride | HPK 56 hydrochloride,MP470 hydrochloride | Others |
Amuvatinib hydrochloride (MP470 hydrochloride) is an orally administred multi-targeted tyrosine kinase inhibitor that exhibits strong efficacy against mutant forms of c-Kit, PDGFRα, Flt3, c-Met, and c-Ret, while also act... | |||
T74501 | NHEJ inhibitor-1 | ||
NHEJ Inhibitor-1 (Compound C2), a trifunctional Pt(II) complex, mitigates non-homologous end joining (NHEJ)/homologous recombination (HR)-related double strand break (DSB) repairs, combating Cisplatin resistance in non-s... | |||
T83854 | BRC4wt TFA | ||
BRC4wt, an acetylated peptide originating from the BRC4 repeat within human BRCA2 (1521-1536), acts as an inhibitor of the BRCA2 and RAD51 protein-protein interaction. When linked to the cationic cell-penetrating peptide... |